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A report on the 15th International Mouse Genome
Conference, Edinburgh, UK, 21-24 October 2001.
The mouse genome sequence
In  a  year  notable  for  the  completion  of  a  draft  human
genome sequence, it was appropriate that a major topic
at the 15th International Mouse Genome Conference was
a  discussion  of  the  status  of  the  mouse  genome  project.
Details of the public-domain effort were presented by John
McPherson (Washington University, St Louis, USA), Kerstin
Lindblad-Toh  (Whitehead  Institute,  Cambridge,  USA),
Shaying  Zhao  (The  Institute  for  Genomic  Research,
Rockville,  USA),  Anne-Marie  Mallon  (Medical  Research
Council  Mouse  Genome  Centre  and  Mammalian  Genetics
Unit  (MRC  MGU/MGC),  Harwell,  UK),  and  Jim  Thomas
(National  Human  Genome  Research  Institute,  National
Institutes of Health (NIH), Bethesda, USA). The approach
being taken combines sequencing of bacterial artificial chro-
mosomes (BACs) - this was the main method for sequencing
the human genome - and whole-genome shotgun sequenc-
ing, which is advocated by investigators at Celera Genomics.
A  fingerprinted  physical  map  of  300,000  BAC  clones  has
been generated and aligned to the mouse radiation-hybrid
map  using  sequence-tagged  sites  (STSs)  derived  from
microsatellite  sequences  and  expressed  sequence  tags
(ESTs). The precise position of the BACs on the map is being
refined with the help of the sequences of the ends of many of
the  BACs.  Nearly  threefold  (3x)  coverage  of  the  genome
using shotgun sequence has been completed and deposited
in public domain databases. 
One aim of the public mouse genome-sequencing effort is to
generate  shotgun-sequence  reads  from  different  mouse
strains, in order to identify single-nucleotide polymorphisms
(SNPs). (As plans for this component are in development, we
propose that the validation and characterization of SNPs in a
large number of commonly used inbred strains is as important
as SNP discovery itself, and urge that appropriate resources be
devoted to it). An important part of genomics is the informat-
ics required for data management and analysis; programs for
organizing  and  annotating  mouse  genome  sequence  in  the
Ensembl  project  [http://mouse.ensembl.org/]  and  at  the
National  Center  for  Biotechnology  Information  (NCBI
[http://www.ncbi.nlm.nih.gov/genome/guide/M_musculus.
html]) were  presented  by  Tim  Hubbard  (Sanger  Centre,
Hinxton, UK) and Deanna Church (NCBI, NIH, Bethesda,
USA), respectively. 
The  other  sequencing  effort  for  the  mouse  genome  is  the
proprietary  sequence  completed  by  Celera  Genomics,
described  by  Gene  Myers  (Celera  Genomics,  Rockville,
USA).  Myers  and  colleagues  have  assembled  a  reasonably
complete mouse sequence using only 5.3x shotgun sequence
coverage  together  with  a  bioinformatic  assembly  protocol
that combines analysis of sequence identity between shotgun
sequence reads with ‘mate-pair’ information, that is, infor-
mation from the pairing of reads derived from opposite ends
of  each  clone.  Although  some  investigators  have  noted
errors in the assembled sequence - and it is not clear what is
being done to correct these - there can be little argument
that Celera’s work provides an extremely valuable resource
to those who have access to it. It also validates the assertion
made by Craig Venter and colleagues (Celera) that assembly
of complex genome sequences using only shotgun sequence
data is feasible; the Celera human genome assembly was not
a conclusive validation because it used public-domain BAC
sequences as well as shotgun sequence. 
An  emerging  theme  in  genomic  science  is  the  power  of
comparative analysis for identification of genes and regu-
latory regions. This was highlighted in a plenary presenta-
tion  by  Jean  Weissenbach  (Genoscope,  Paris,  France)
describing progress in sequencing the freshwater pufferfish2 Genome Biology Vol 3 No 2  Beier and Herron
Tetraodon  nigroviridis,  which  has  a  genome  about  an
eighth the size of that of humans or mice. In addition to the
3x  sequence  coverage  that  has  been  deposited  in  the
GenBank genome sequence survey database, Weissenbach
and  colleagues  have  developed  a  database  of  ‘Ecores’,
sequences  that  are  conserved  between  pufferfish  and
humans and that are therefore likely to be coding regions
([http://www.genoscope.cns.fr/proxy/cgi-bin/exofish.cgi]). 
With  the  rapidly  progressing  sequencing  of  the  mouse
genome  comes  the  possibility  of  performing  true  genome-
wide  investigation  using  techniques  that  permit  massively
parallel analysis, such as expression profiling, similar to the
kinds  of  studies  that  have  now  been  done  in  yeast  and
Caenorhabditis  elegans.  For  example,  a  database  of  the
tissue-specific expression levels of murine genes, containing
2. 5x1 0 6 independent  measurements,  has  been  generated
using hybridization to Affymetrix oligonucleotide arrays (Tim
Wiltshire,  Genomics  Institute  of  the  Novartis  Foundation,
San Diego, USA). Expression profiling has also been used to
identify genes that are expressed in sexually dimorphic pat-
terns during development; these were validated using whole-
mount  in  situ analysis  of  gonads  (Lee  Smith,  MRC
MGC/MGU, Harwell). Among other approaches to genome-
wide analysis that were also presented was a large set of full-
length cDNAs generated by RIKEN, which is being further
explored  using  a  high-throughput  two-hybrid  screening
approach to identify protein-protein interactions (Harukazu
Suzuki,  RIKEN,  Yokohama,  Japan).  Over  500  interactions
have  been  identified  so  far.  Also,  Bill  Stanford  (Samuel
Lunenfeld  Research  Institute,  Toronto,  Canada)  described
one of several active large-scale programs for gene trapping,
in which reporter constructs are randomly inserted into the
genome and are expressed only if they insert within a gene.
As  well  as  being  a  resource  with  tremendous  potential  for
annotation of gene function in its own right, the generation
of  large  sets  of  STS-tagged  gene-trapped  embryonic  cell
lines by this project also provides a means to test candidate
loci identified by phenotype-driven mutagenesis screens. 
Mutagenesis
The mutagenesis session did not focus on large centers with
broad aims but instead highlighted innovative approaches to
screens focused on a particular region of the genome or on a
specific phenotype. Although new approaches to the genera-
tion of mutations were briefly discussed, it is clear that ethyl-
nitrosourea (ENU) remains the dominant method. Monica
Justice (Baylor College of Medicine, Houston, USA) opened
the session with an update on the Baylor ENU screen for
mutations on mouse Chromosome 11. This screen uses a bal-
ancer-chromosome  strain  that  provides  a  way  to  readily
identify  mice  homozygous  for  an  engineered  inversion  in
recessive  screens,  making  stock  maintenance  straightfor-
ward. A wide variety of mutant phenotypes were described,
many of which are embryonic-lethal.
Specialized  phenotype  screens  were  a  major  focus  of  the
session.  Karen  Steel  (MRC  Institute  of  Hearing  Research,
Nottingham) presented ongoing screens designed to identify
and  classify  mice  with  inner-ear  defects  arising  from  the
mutagenesis program at the MRC MGC/MGU. Using a com-
bination  of  inner-ear  pathology  and  genetic  mapping,
several  complementation  groups  were  defined;  several  of
these  mapped  to  previously  known  vestibular  defects  in
mice, but new loci were also uncovered. One example of a
new  locus  is  Pardon,  mutants  in  which  have  malformed
auditory ossicles; Pardon has been identified as a mutation
in Emx2, a homeobox-containing gene.
Discovery of new mutations from large mutagenesis centers
will rely heavily on methods for screening large numbers of
mice robustly and efficiently. Working in collaboration with
the Munich ENU center (GSF Research Center for Environ-
ment and Health), Heinrich Flaswinkel (Technische Univer-
sität, Munich, Germany) presented a method to identify mice
with  immunological  defects  through  fluorescence-activated
cell  sorting  (FACS)  and  enzyme-linked  immunosorbent
assay (ELISA) analysis. This approach was reported to identify
54 heritable phenotypes from 8,857 lines screened. John Schi-
menti (Jackson Laboratory, Bar Harbor, USA) introduced a
novel  method  for  identifying  mice  with  defects  leading  to
genome instability. Mice are irradiated and bone marrow is
isolated for flow cytometry; those with defects in DNA repair
pathways,  for  example,  will  have  a  higher  concentration  of
micronuclei and can be readily identified. 
One benefit of point mutations, which are produced by ENU,
is  that  they  often  produce  hypomorphic  alleles  and  could
thus complement the functional analysis of a gene for which
a null mutation has already been generated. Two talks pre-
sented approaches directed at identification of more muta-
tions in known genes from populations of mutagenized mice.
Jay Vivian (University of North Carolina, Chapel Hill, USA)
discussed  the  use  of  denaturing  high-performance  liquid
chromatography  (DHPLC)  to  identify  differences  in  Smad
genes in mutagenized embryonic stem (ES) cells. Smads are
intracellular  proteins  involved  in  signaling  through  the
transforming  growth  factor   (TGF)  family  of  receptors.
This  approach  identified  approximately  one  coding-
sequence mutation per 2 kilobases of the Smad2 gene, and
when the mice were generated from the mutant ES cells, one
of the mutations resulted in a phenotype similar to that of
Smad2 knockout  mice.  Emma  Coghill  (MRC  MGC/MGU)
presented  a  sequence-based  approach,  screening  archived
sperm  from  the  Harwell  ENU  mutagenesis  program.  Her
analysis provided a new allele of connexin 26 that had an
embryonic-lethal phenotype.
Gene discovery
As the whole of the mouse genome sequence becomes avail-
able, the positional cloning of many interesting mutations isc
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being accelerated, as was evident in the array of topics dis-
cussed in the Gene Discovery session of the meeting. The
successes described below were not solely due to genome-
sequencing  efforts,  however;  other  emerging  technologies,
such as cross-species mapping and gene trapping, were also
used to identify mutations.
The  session  was  opened  by  Adrian  Bird  (Wellcome  Trust
Center  for  Cell  Biology,  Edinburgh,  UK)  who  presented
recent data on a new mouse model for Rett syndrome, a pro-
gressive  neurological  disorder  that  primarily  affects  girls.
The mutated gene in this syndrome in humans encodes the
DNA-binding protein MeCP2, which is known to selectively
bind CpG DNA motifs; the mechanism by which its absence
results in the syndrome is unclear, however. Bird presented
details of the mouse null mutation that faithfully recapitu-
lates several aspects of the human disorder in heterozygotes,
including ataxia and breathing dysrhythmia. 
Mouse models of polycystic kidney disease have provided
much  information  over  the  years  about  normal  kidney
development.  We  (D.B.)  described  our  finding  that  the
recessive polycystic kidney mutation jck is in a gene encod-
ing  a  novel  Nek-family  kinase.  We  have  taken  a  new
approach to validate the function of the mammalian gene:
using an antisense morpholino oligonucleotide in zebrafish
to  reduce  expression  of  the  kinase,  the  cystic  phenotype
was recapitulated, confirming the importance of this gene
in  normal  kidney  development. A  gene  that  could  be  of
potential therapeutic benefit was identified by analysis of
heterozygote  WldS/+ mice,  which  show  resistance  to
motor-neuron axon degeneration after transection (Michael
Coleman, University of Cologne, Germany). A novel fusion
between  the  ubiquitination  gene  E4B and  the  gene  for
nicotinamide mononucleotide adenyltransferase was identi-
fied in the WldS strain. Expression of a transgenic fusion
gene in mice reproduced the phenotype, implying that mod-
ulation  of  pyridine  nucleotide  metabolism  may  protect
against axon degeneration.
Rescue of mutants by BAC transgenes is another powerful
technique that is becoming common practice in positional-
cloning  projects.  This  approach  was  used  by  Philomena
Mburu (MRC MGC/MGU) in combination with a detailed
phenotypic analysis of inner-ear hair cells to narrow down
the candidate genes to be tested for mutations in  whirler
mice, which have inner-ear defects. A novel gene was pre-
sented, encoding a PDZ-domain-containing protein, that is
implicated in the development of stereocilia.
Genetic studies of coat-color defects in mice have provided
much information on how the genes involved might interact.
For example, the products of the dilute, ashen, and leaden
genes are all thought to function in the same biochemical
pathway,  transporting  melanin  from  melanosome  to  pig-
mented hair cells. Using a candidate gene approach, Lydia
Matesic  (National  Cancer  Institute,  Frederick,  USA)  has
found  a  novel  effector  protein  for  the  small  GTPase  Rab,
called Mlph, that is mutated in leaden. 
Cross-species comparative analysis is an approach that was
used  by  several  speakers  to  identify  candidate  genes  for
mouse mutations. This approach has facilitated the cloning
of  the  genes  defective  in  myodystrophy mutants  (Pam
Grewal, University of Nottingham, UK), in flavivirus suscep-
tibility mutants  (Tomoji  Mashimo,  Institut  Pasteur,  Paris,
France) and in a rat mutant queue courte (Kazuhiro Kitada,
Kyoto  University,  Japan).  Along  with  other  strategies  pre-
sented in this session, the success of this technique shows that
a major bottleneck in positional cloning - gene identification -
is quickly becoming resolved. 
Developmental genetics
Developmental  genetics  has  been  of  increasing  interest  at
successive  international  mouse  genome  meetings.  This
year’s session was opened by two talks that focused on epige-
netic programming in cloned embryos. Ian Wilmut (Roslin
Institute,  Roslin,  UK)  presented  information  about  the
success of embryo cloning in several species. The current low
success rates are attributed to inappropriate gene expression
that may be due in part to a failure to maintain developmen-
tally  appropriate  imprinting  in  transferred  somatic  cell
nuclei.  This  hypothesis  was  supported  by  a  presentation
from Kevin Eggan (Whitehead Insitute, Cambridge, USA),
who  described  differences  in  imprinted  gene  expression
between cloned and normal mouse embryos. 
The imprinting theme was continued in a talk from Jesse
Mager (University of North Carolina, Chapel Hill, USA), who
discussed X-chromosome inactivation. The embryonic ecto-
derm development gene was shown to be important for the
maintenance of inactivation of the paternal X chromosome
in female mice, as well as for development of trophoblast
giant cells in female embryos. This gene has been proposed
to interact with a histone deacetylase in the extraembryonic
tissue, selectively deactivating the paternal X chromosome.
Skin and hair defects are a group of phenotypes that have
been well studied by mouse geneticists, and three talks in
this session were focused on a better understanding of these
phenotypes.  Karen  Fitch  (Stanford  University,  Palo  Alto,
USA)  described  the  classification  of  mice  with  dark  skin
phenotypes from the GSF mutagenesis program (Munich,
Germany).  The  mutants  were  further  categorized  using  a
melanocyte-specific reporter system, mapped, and assigned
to  ten  linkage  groups.  Teresa  Gunn  (Cornell  University,
Ithaca, USA) described recent work characterizing alleles of
mahogany, which was originally identified as a coat-color
mutant but alleles of which have now been found to cause
behavioral  abnormalities  caused  by  a  degenerative  neu-
ropathy. Lastly, we (B.H.) described a mutation in a geneencoding a p53-binding-protein homolog in waved3 mice,
which have abnormalities in skin and heart development.
A major benefit of mouse models is their utility in providing
a better understanding of disease in humans. The presenta-
tion of Kenro Kusumi (University of Pennsylvania, Philadel-
phia, USA), describing the role of mutations in the Dll3 gene,
which  encodes  a  Delta-like  ligand  for  Notch  proteins,  in
pudgy mice,  which  have  vertebral  and  rib  malformations,
underscored the usefulness of this approach. Comparison of
the mouse model to the human disorder spondylocostal dys-
tosis  provides  some  insight  into  potential  neurological
defects in humans, as well as into the function of this gene in
normal somitogenesis.
Finally,  although  mapping  of  the  loci  contributing  to  a
complex trait is often readily done, identifying the causal
gene(s)  remains  daunting,  even  in  a  well-defined  genetic
system such as the mouse. Sarah Lloyd (Imperial College of
Medicine at St Mary’s, London, UK) reported the mapping
of quantitative trait loci affecting incubation times of prion
disease,  and  Ayo  Toye  (MRC  MGC/MGU)  reported
mapping  of  diabetes  intermediate  phenotypes.  Alain
Balmain  (University  of  California,  San  Francisco,  USA)
described progress in characterizing a locus that modifies
susceptibility to skin cancer and reported that haplotype
analysis  of  susceptible  and  resistant  strains  facilitated
localization to a small genetic interval.
Next  year’s  International  Mouse  Genome  Conference
will be held in San Antonio, USA. With the imminent com-
pletion of the public-domain mouse genome sequence, the
productivity of the diverse mutagenesis programs, and the
increasing sophistication of genome manipulation technolo-
gies such as gene trapping and BAC transgenesis, we antici-
pate that many exciting discoveries in mammalian biology
will be reported. 
4 Genome Biology Vol 3 No 2  Beier and Herron